Revolade Tablet (Eltrombopag)
Eltrombopag is an oral medication that belongs to the class of drugs known as thrombopoietin receptor agonists. It is commonly marketed under the brand name Revolade and Promacta and is used to treat certain blood disorders, specifically thrombocytopenia.
Introduction of Revolade Tablet (Eltrombopag)
Eltrombopag is an oral medication that belongs to the class of drugs known as thrombopoietin receptor agonists. It is commonly marketed under the brand name Revolade and is used to treat certain blood disorders, specifically thrombocytopenia. Thrombocytopenia is a condition characterized by a Low Platelet Count in the Blood, which can increase the risk of bleeding. Promacta is another brand name for Eltrombopag. It is marketed under this name in certain countries, including the United States. The medication is identical, and its uses and dosage information remains the same.
Eltrombopag dosage forms:
Eltrombopag is primarily available in tablet form. The tablets come in different dosage strengths, typically ranging from 25 mg to 75 mg. The specific dosage form and strength prescribed will depend on the individual's medical condition and the healthcare professional's assessment. It is important to follow the prescribed dosage and instructions provided by a healthcare professional when taking Eltrombopag. The dosage of Eltrombopag can vary depending on the individual's medical condition and response to treatment. It is important to follow the prescribed dosage and instructions provided by a healthcare professional. Typically, Eltrombopag is available in tablet form and is taken once daily, with or without food.
In addition to ITP, Eltrombopag may also be used in the treatment of severe aplastic anemia (SAA) in patients who have not responded to other forms of therapy. SAA is a rare disorder in which the bone marrow fails to produce enough blood cells, including platelets. By promoting the production of platelets, Eltrombopag can help improve blood cell counts and reduce the need for blood transfusions in SAA patients. It is important to note that Eltrombopag should be used under the supervision of a healthcare professional, as regular monitoring of blood cell counts and liver function is required during treatment. The dosage may need to be adjusted based on individual response and any side effects experienced.
Eltrombopag buy at 1mgstore.com:
Eltrombopag is available for purchase at 1mgstore.com. However, 1mgstore.com is an online pharmacy that sells a variety of medications, so it is possible that Eltrombopag may be available for purchase on its website. It is always recommended to consult with a healthcare professional or pharmacist for guidance on purchasing prescription medications.
Some Of The Safety Advice To be Noticed While Using Revolade Tablet (Eltrombopag)
Allergies: Before taking Eltrombopag or Promacta, it is important to inform your healthcare provider about any known allergies to this medication or any other drugs. Allergic reactions to Eltrombopag can be serious and may include symptoms such as rash, itching, swelling, severe dizziness, or difficulty breathing.
Liver problems: Eltrombopag can affect liver function. It is crucial to inform your healthcare provider if you have a history of liver disease, hepatitis, or any other liver-related conditions. Regular monitoring of liver function may be required during treatment with Eltrombopag.
Blood clotting disorders: Eltrombopag can increase the risk of blood clotting. It is essential to inform your healthcare provider if you have a history of blood clotting disorders or if you are taking any medications that may increase the risk of blood clots.
Bleeding disorders: Eltrombopag can cause an increased risk of bleeding. If you have a bleeding disorder or are taking medications that affect blood clotting, it is important to discuss this with your healthcare provider before starting Eltrombopag.
Pregnancy and breast-feeding: It is essential to inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. The safety of Eltrombopag during pregnancy and breastfeeding has not been established, and it should only be used if the potential benefits outweigh the risks.
Eltrombopag tablet (Revolade) is used for various purposes in the treatment of certain blood disorders.
Chronic immune thrombocytopenia (ITP): Eltrombopag is approved for the treatment of chronic immune thrombocytopenia in adults and children who are at least 1 year old. ITP is an autoimmune disorder characterized by a low platelet count, leading to an increased risk of bleeding. Eltrombopag works by stimulating the production of platelets in the bone marrow, helping to increase the platelet count and reduce the risk of bleeding.
Severe aplastic anemia (SAA): Eltrombopag/Promacta is also used in the treatment of severe aplastic anemia in patients who have not responded to other forms of therapy. SAA is a rare condition in which the bone marrow fails to produce enough blood cells, including platelets. By promoting the production of platelets, Eltrombopag can help improve blood cell counts and reduce the need for blood transfusions in SAA patients.
Thrombocytopenia in chronic liver disease: Eltrombopag can be used to treat thrombocytopenia (low platelet count) in patients with chronic liver disease who are scheduled to undergo a medical procedure. It helps increase platelet counts and reduce the risk of bleeding during invasive procedures.
Some of The Potential After Effects of Revolade Tablet (Eltrombopag)
Life-threatening blood clots: Eltrombopag may increase the risk of life-threatening blood clots, especially in individuals with certain risk factors. Seek immediate medical attention if you experience symptoms such as sudden shortness of breath, chest pain, or swelling in the arms or legs.
Worsening of blood disorders: In rare cases, Eltrombopag may cause the worsening of blood disorders, including ITP or SAA. It is important to be aware of any changes in your blood cell counts and report them to your healthcare provider.
Liver problems: Eltrombopag/Promacta can affect liver function and may cause liver problems, including elevated liver enzymes or jaundice. Contact your healthcare provider if you experience symptoms such as yellowing of the skin or eyes, dark urine, or persistent abdominal pain.
Nausea and vomiting: Common side effects of Eltrombopag include nausea and vomiting. These side effects are usually mild and can be managed with over-the-counter remedies or by adjusting the timing of the medication.
Headache and dizziness: Some individuals may experience headaches or dizziness while taking Eltrombopag. If these symptoms persist or worsen, it is recommended to consult your healthcare provider.
Fatigue and weakness: Eltrombopag may cause fatigue and weakness. If you experience excessive tiredness or weakness that interferes with your daily activities, inform your healthcare provider.
Muscle or joint pain: Eltrombopag may cause muscle or joint pain. If you experience severe or persistent pain, it is important to seek medical attention.
Changes in taste: Eltrombopag can cause changes in taste perception, including a metallic taste in the mouth. These changes are usually temporary and resolve once the medication is discontinued.
Inquiries May Get About Revolade Tablet (Eltrombopag)
Can Eltrombopag be considered a life-saving drug?
Eltrombopag is not classified as a life-saving drug. However, it is an important medication used in the treatment of certain blood disorders, such as chronic immune thrombocytopenia (ITP) and severe aplastic anemia (SAA). These conditions can be serious and may require medical intervention to manage symptoms and improve blood cell counts. Eltrombopag helps increase platelet production, reducing the risk of bleeding and the need for blood transfusions. While it is not a life-saving drug in the traditional sense, it plays a significant role in improving quality of life and managing these conditions.
Can Eltrombopag/Promacta affect blood donation eligibility?
Yes, Eltrombopag can affect blood donation eligibility. Individuals taking Eltrombopag should not donate blood due to the potential risk of transmitting the medication to the recipient. It is important to inform healthcare providers, blood donation centers, and blood banks about any medications you are taking to ensure the safety of the donated blood.
Can Eltrombopag be used in pediatric patients?
Yes, Eltrombopag can be used in pediatric patients. It is approved for the treatment of chronic immune thrombocytopenia (ITP) in children who are at least 1 year old. The dosage and administration may vary based on the child's age, weight, and medical condition. Pediatric patients should be closely monitored by healthcare professionals during treatment with Eltrombopag.
Can Eltrombopag be taken with food?
Yes, Eltrombopag can be taken with or without food. It does not have specific food requirements. However, it is important to follow the instructions provided by your healthcare provider or the medication's label. If you have any concerns or questions regarding food interactions, it is advisable to consult with your healthcare provider or pharmacist.
Can Eltrombopag cure chronic immune thrombocytopenia (ITP)?
Eltrombopag is not a cure for chronic immune thrombocytopenia (ITP). It is a medication that helps increase platelet production in the bone marrow, thereby improving blood cell counts and reducing the risk of bleeding. However, the underlying cause of ITP, which involves an autoimmune response, is not addressed by Eltrombopag. The goal of treatment is to manage the symptoms and improve platelet counts, but the condition may require ongoing management and monitoring.
Potential Drug Connection With Eltrombopag/Promacta Tablet are:
Blood-thinning medications: Eltrombopag/Promacta may interact with blood-thinning medications, such as warfarin, increasing the risk of bleeding. It is crucial to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins.
Acid-reducing medications: Acid-reducing medications, such as antacids or proton pump inhibitors, can reduce the effectiveness of Eltrombopag. It is recommended to take Eltrombopag at least 4 hours before or after taking medications that lower stomach acid.
Certain antibiotics and antiviral drugs: Some antibiotics (e.g., clarithromycin) and antiviral drugs (e.g., ritonavir) can increase the concentration of Eltrombopag in the body, potentially leading to an increased risk of side effects. Close monitoring and dosage adjustments may be necessary if these medications are used together.
Herbal supplements: Certain herbal supplements, such as St. John's Wort, may decrease the effectiveness of Eltrombopag. It is important to discuss the use of herbal supplements with your healthcare provider before starting Eltrombopag.
Eltrombopag cost: You Can Check the cost of Eltrombopag at our website, which can vary depending on various factors such as the dosage strength, quantity, and the region or country in which it is purchased.
| Manufacturer | : | GSK Pharma, India |
| Equivalent Brand | : | Promacta |
| Generic Search | : | Eltrombopag |
